Covered recipient · General Payments record
CAMILLE LAST
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$750.11
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.56 | 15 |
| Education | $68.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $172.09 | 5 |
| ABBVIE INC. | $59.29 | 3 |
| Hologic Sales and Service, LLC | $32.45 | 2 |
| Exeltis, USA Inc. | $28.72 | 2 |
| SHIELD THERAPEUTICS INC | $19.85 | 1 |
| Novo Nordisk AS | $19.49 | 1 |
| Biogen, Inc. | $18.80 | 1 |
| Organon LLC | $16.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.33 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107512251 | CMS |
| ABBVIE INC. | $20.49 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107512253 | CMS |
| ABBVIE INC. | $22.47 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107512255 | CMS |
| Astellas Pharma US Inc | $25.09 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139491738 | CMS |
| Astellas Pharma US Inc | $21.37 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139533092 | CMS |
| Astellas Pharma US Inc | $68.99 | 09/06/2024 | Education | Undisputed | 01/23/2026 | 1139540118 | CMS |
| Astellas Pharma US Inc | $31.90 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139548445 | CMS |
| Astellas Pharma US Inc | $24.74 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139552729 | CMS |
| Biogen, Inc. | $18.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104855854 | CMS |
| Exeltis, USA Inc. | $13.63 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150015103 | CMS |
| Exeltis, USA Inc. | $15.09 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150015105 | CMS |
| Hologic Sales and Service, LLC | $14.26 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084881078 | CMS |
| Hologic Sales and Service, LLC | $18.19 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084881110 | CMS |
| Novo Nordisk Inc | $19.49 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100238656 | CMS |
| Organon Llc | $16.86 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136207257 | CMS |
| SHIELD THERAPEUTICS INC | $19.85 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150145636 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.